Thu, Mar 5, 2015, 5:55 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Oct 26, 2012 9:40 AM Flag


    All the bad news seems to be out now, shorts might start covering here. If T-DM1 gets priority review the stock will move up, the negative royalty news is out, significant revs will be coming in to IMGN starting next year. Even considering I don't have trust/faith in Junius, this might be a good time to buy for a trade IMO. It is possible the price target for IMGN will be reduced by a few of the more bullish analysts, so maybe a low bid will catch a good price drop. $13 is being tested now, let's see if IMGN has any buyers.

7.87+0.140(+1.81%)Mar 5 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.